La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Kromek Group Bilan de santé

Santé financière contrôle des critères 3/6

Kromek Group possède un total de capitaux propres de £47.3M et une dette totale de £8.9M, ce qui porte son ratio d'endettement à 18.8%. Son actif total et son passif total sont £68.7M et de £21.4M.

Informations clés

18.8%

Ratio d'endettement

UK£8.90m

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	UK£3.72m
Fonds propres	UK£47.31m
Total du passif	UK£21.43m
Total des actifs	UK£68.75m

Mises à jour récentes de la santé financière

Kromek Group (LON:KMK) Is Carrying A Fair Bit Of Debt

Aug 04

Recent updates

A Piece Of The Puzzle Missing From Kromek Group plc's (LON:KMK) 36% Share Price Climb

Apr 20

Here's Why Shareholders Should Examine Kromek Group plc's (LON:KMK) CEO Compensation Package More Closely

Sep 02

Kromek Group's (LON:KMK) Shareholders Are Down 44% On Their Shares

Jan 14

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de KMK ( £22.0M ) dépassent ses passifs à court terme ( £10.7M ).

Passif à long terme: Les actifs à court terme de KMK ( £22.0M ) dépassent ses passifs à long terme ( £10.8M ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de KMK ( 11% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de KMK est passé de 13.6% à 18.8% au cours des 5 dernières années.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: Données insuffisantes pour déterminer si KMK dispose de suffisamment de piste de trésorerie sur la base de son flux de trésorerie disponible actuel.

Prévisions de trésorerie: Données insuffisantes pour déterminer si KMK dispose de suffisamment de piste de trésorerie si son flux de trésorerie disponible continue de croître ou de diminuer en fonction des taux historiques.

Kromek Group Bilan de santé

Santé financière contrôle des critères 3/6

Informations clés

Mises à jour récentes de la santé financière

Kromek Group (LON:KMK) Is Carrying A Fair Bit Of Debt

Recent updates

Price target increased by 9.8% to UK£0.28

New minor risk - Financial data availability

A Piece Of The Puzzle Missing From Kromek Group plc's (LON:KMK) 36% Share Price Climb

Kromek Group plc (LON:KMK) Soars 46% But It's A Story Of Risk Vs Reward

Kromek Group plc, Annual General Meeting, Mar 04, 2024

Kromek Group plc Grants £1.3 Million Under Horizon Europe Guarant Scheme New Joint Project to Develop AI-Powered Radiation Sensor Powered by Artificial Intelligence

First half 2024 earnings released: UK£0.005 loss per share (vs UK£0.012 loss in 1H 2023)

Kromek Group plc to Report First Half, 2024 Results on Jan 30, 2024

New minor risk - Financial data availability

Kromek Group plc's (LON:KMK) Price In Tune With Revenues

Kromek Group plc, Annual General Meeting, Sep 28, 2023

Kromek Group plc Provides Earnings Guidance for the Fiscal Year 2024

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Kromek Group plc has completed a Follow-on Equity Offering in the amount of £1.028219 million.

Kromek Group plc has completed a Follow-on Equity Offering in the amount of £7 million.

Kromek Group plc's (LON:KMK) Revenues Are Not Doing Enough For Some Investors

First half 2023 earnings released: UK£0.012 loss per share (vs UK£0.005 loss in 1H 2022)

Price target decreased to UK£0.27

Less than half of directors are independent

Kromek Group plc, Annual General Meeting, Sep 28, 2022

Kromek Group plc announced that it has received £1.14 million in funding

Kromek Group plc announced that it has received £1.7 million in funding

Kromek Group (LON:KMK) Is Carrying A Fair Bit Of Debt

Full year 2022 earnings: EPS misses analyst expectations

Kromek Group plc Provides Earnings Outlook for the Year Ended 30 April 2022

Price target decreased to UK£0.38

Less than half of directors are independent

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's Why Shareholders Should Examine Kromek Group plc's (LON:KMK) CEO Compensation Package More Closely

Full year 2021 earnings released: UK£0.015 loss per share (vs UK£0.048 loss in FY 2020)

Full year 2021 earnings released: UK£0.015 loss per share (vs UK£0.048 loss in FY 2020)

Kromek Group plc Provide Earnings Guidance for the Year Ended April 30, 2021

Kromek Group plc Awards Nuclear Detection Contract

Kromek Wins Medical Screening and Nuclear Security Orders

Kromek Group plc has completed a Follow-on Equity Offering in the amount of £10 million.

New 90-day high: UK£0.20

Kromek Group's (LON:KMK) Shareholders Are Down 44% On Their Shares

First half 2021 earnings released: UK£0.009 loss per share

Kromek Group plc Announces Funding to Advance Bio-Threat Detection Solution

Kromek Group plc Announces Management Changes

Kromek Group plc to Report First Half, 2021 Results on Jan 13, 2021

Kromek Group plc Launches the D5 RIID Radiation Detector

Rmd’S Cllbc Technology Successfully Integrated in Kromek’S Riid

Kromek Group plc Commences Development of A New System to Improve the Pathological Medical Imaging Techniques Used During Cancer Surgery

Full year earnings released

Annual earnings released: Revenue misses expectations

Kromek Group plc Appoints Rakesh Sharma Obe as A Non-Executive Director

Kromek Launches the D3 PRD High-Accuracy Personal Radiation Detector

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des pistes de trésorerie

Découvrir des entreprises saines